Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 24, 2019

Primary Completion Date

February 14, 2025

Study Completion Date

February 14, 2025

Conditions
Advanced Renal Cell Carcinoma
Interventions
OTHER

Carevive software

In this study, Carevive will deliver a link to subjects so that an online survey can be completed. The survey will occur weekly for the first 12 weeks of the study and will be spaced out to every other week thereafter. The questions will mostly focus on side effects from their cancer therapy, as well as a few questions about drug compliance and healthcare utilization. After completion of the survey, the subject will be given a care plan with at home self-management options for drug-related toxicities.

Trial Locations (1)

14642

University of Rochester - Wilmot Cancer Institute, Rochester

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Rochester

OTHER

NCT03229083 - Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter